Drug intelligence / Profile preview

IDEOS

Development stage
Phase 4
Lead developer
INNOTHERA
Modality
Small Molecules
Administration
Oral
01

Overview

IDEOS is a fixed-dose combination of calcium carbonate and vitamin D3 (cholecalciferol) developed and manufactured by the French pharmaceutical company INNOTHERA. It is primarily indicated for the correction of combined calcium and vitamin D deficiencies in elderly patients and as a supplement in the management of osteoporosis where there is a risk of such deficiencies. Each chewable tablet typically contains 500 mg of elemental calcium (provided as 1250 mg of calcium carbonate) and 400 IU of vitamin D3. The product works by providing the necessary mineral substrate for bone mineralization while the vitamin D3 component enhances the intestinal absorption of calcium and its subsequent fixation in bone tissue. IDEOS is approved and marketed as an over-the-counter (OTC) medication in several countries, including France, Saudi Arabia, and Ireland.

Brand names
IDEOS
Other names
calcium carbonate + cholecalciferolcalcium + vitamin D3
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on IDEOS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IDEOS.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call